Request Sample Inquiry
Digital Therapeutics Market

Digital Therapeutics Market

Digital Therapeutics Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

156

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1327

Segments Covered
  • By Application By Application Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others
  • By End-Use By End-Use Patients, Providers, Payers, Employers, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 4.8 Billion
Revenue 2030Revenue 2030: USD 18.72 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 30.08%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Digital Therapeutics Market Segment Analysis

  • Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Diabetes
    • Obesity
    • CVD
    • CNS Disease
    • Respiratory Diseases
    • Smoking Cessation
    • Others
  • Digital Therapeutics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Patients
    • Providers
    • Payers
    • Employers
    • Others
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Digital Therapeutics Market, by Application
        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others
      • North America Digital Therapeutics Market, by End-Use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • U.S.
        • U.S. Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • U.S. Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Canada
        • Canada Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Canada Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Mexico
        • Mexico Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Mexico Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Europe
      • Europe Digital Therapeutics Market, by Application
        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others
      • Europe Digital Therapeutics Market, by End-Use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • U. K.
        • U.K. Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • U.K. Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • France
        • France Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • France Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Germany
        • Germany Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Germany Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Italy
        • Italy Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Italy Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Spain
        • Spain Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Spain Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Europe
        • Rest of Europe Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Rest of Europe Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Asia Pacific
      • Asia Pacific Digital Therapeutics Market, by Application
        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others
      • Asia Pacific Digital Therapeutics Market, by End-Use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • China
        • China Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • China Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Japan
        • Japan Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Japan Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Germany
        • Germany Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Germany Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • India
        • India Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • India Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • South Korea
        • South Korea Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • South Korea Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • South East Asia
        • South East Asia Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • South East Asia Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Asia Pacific
        • Rest of Asia Pacific Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Rest of Asia Pacific Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Latin America
      • Latin America Digital Therapeutics Market, by Application
        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others
      • Latin America Digital Therapeutics Market, by End-Use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • Brazil
        • Brazil Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Brazil Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Argentina
        • Argentina Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Argentina Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Latin America
        • Rest of Latin America Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Rest of Latin America Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Middle East & Africa
      • Middle East & Africa Digital Therapeutics Market, by Application
        • Diabetes
        • Obesity
        • CVD
        • CNS Disease
        • Respiratory Diseases
        • Smoking Cessation
        • Others
      • Middle East & Africa Digital Therapeutics Market, by End-Use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • GCC Countries
        • GCC Countries Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • GCC Countries Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • South Africa
        • South Africa Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • South Africa Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Digital Therapeutics Market, by Application
          • Diabetes
          • Obesity
          • CVD
          • CNS Disease
          • Respiratory Diseases
          • Smoking Cessation
          • Others
        • Rest of Middle East & Africa Digital Therapeutics Market, by End-Use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
FAQ
Frequently Asked Question
  • The global Digital Therapeutics valued at USD 4.8 Billion in 2022 and is expected to reach USD 18.72 Billion in 2030 growing at a CAGR of 30.08%.

  • The prominent players in the market are Omada Health Inc. (US), WellDoc Inc. (US), 2Morrow Inc (US)., Livongo Health (US), Propeller Health (US), Pear Therapeutics (US), Canary Health Inc. (US), Noom Health Inc. (US), Mango Health Inc. (US), Akili Interactive Labs (South Africa), Better Therapeutics (US), Happify Health (US), Kaia Health (US), Medtronic Plc. (Ireland), Teladoc Health Inc (US), and Fitbit Health Solutions (US)..

  • The market is project to grow at a CAGR of 30.08% between 2023 and 2030.

  • The driving factors of the Digital Therapeutics include

    • Increased Adoption of EHR Solutions

  • North America was the leading regional segment of the Digital Therapeutics in 2022.